KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Shares Issued (2016 - 2025)

Historic Shares Issued for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to $23.7 million.

  • Supernus Pharmaceuticals' Shares Issued rose 58575.97% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year increase of 29390.55%. This contributed to the annual value of $14.9 million for FY2024, which is 12553.71% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Shares Issued of $23.7 million as of Q3 2025, which was up 58575.97% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Shares Issued registered a high of $23.7 million during Q3 2025, and its lowest value of $524000.0 during Q3 2021.
  • Moreover, its 5-year median value for Shares Issued was $2.3 million (2022), whereas its average is $3.7 million.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Shares Issued surged by 692187.5% in 2021, and later tumbled by 8853.6% in 2023.
  • Supernus Pharmaceuticals' Shares Issued (Quarter) stood at $1.6 million in 2021, then soared by 79.62% to $2.8 million in 2022, then plummeted by 61.4% to $1.1 million in 2023, then surged by 529.76% to $6.9 million in 2024, then skyrocketed by 245.22% to $23.7 million in 2025.
  • Its last three reported values are $23.7 million in Q3 2025, $3.3 million for Q2 2025, and $2.0 million during Q1 2025.